Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Eugene Wright"'
Publikováno v:
Clinical Diabetes. 41:81-84
Autor:
Vincent W.S. Wong, Shira Zelber‐Sagi, Kenneth Cusi, Patrizia Carrieri, Eugene Wright, Javier Crespo, Jeffrey V. Lazarus
Publikováno v:
Liver International
Liver International, 2022, 42 (11), pp.2377-2389. ⟨10.1111/liv.15404⟩
Liver International, 2022, 42 (11), pp.2377-2389. ⟨10.1111/liv.15404⟩
Non-alcoholic fatty liver disease (NAFLD) affects at least 25% of the general population and is an increasingly important cause of cirrhosis and hepatocellular carcinoma. Although it is the research focus of the hepatology field, it is clear that pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58808da3ed3152caa1fb70ff81312d15
https://www.hal.inserm.fr/inserm-04051853/document
https://www.hal.inserm.fr/inserm-04051853/document
Publikováno v:
Diabetes. 71
The discordance between the amount of new therapies for Type 2 diabetes (T2D) and improved outcomes highlights an unmet need for tools to help primary care providers (PCPs) make appropriate therapy adjustments. Here we present a novel CGM-based Gluco
Publikováno v:
Diabetes. 71
Healthcare providers (HCP) treating patients who are on basal insulin and have suboptimal glycemic control may benefit from understanding glucose patterns. The primary objective of this study is to evaluate whether a review of Ambulatory Glucose Prof
Autor:
Yehuda Handelsman, Javed Butler, George L. Bakris, Ralph A. DeFronzo, Gregg C. Fonarow, Jennifer B. Green, George Grunberger, James L. Januzzi, Samuel Klein, Pamela R. Kushner, Darren K. McGuire, Erin D. Michos, Javier Morales, Richard E. Pratley, Matthew R. Weir, Eugene Wright, Vivian A. Fonseca
Publikováno v:
Journal of Diabetes and its Complications. 37:108389
Publikováno v:
The Journal of family practice. 69
It is widely known that the extent of time spent in a state of hyperglycemia increases the risk of complications for patients with type 2 diabetes (T2D). However, despite the availability of many antihyperglycemic agents, success in managing T2D has
Autor:
Gregory J. Roberts, Matthew S.D. Kerr, Eugene Wright, Yelena Nabutovsky, Eden Miller, Diana Souto
Publikováno v:
Diabetes. 69
Data on the benefit of continuous glucose monitors (CGM) in people with diabetes not using intensive insulin therapy is limited. We describe clinical outcomes after a FreeStyle Libre® system purchase in people with type 2 diabetes (T2D) not using bo
Publikováno v:
Diabetes. 69
Data for patients with type 2 diabetes (T2D) on long-acting insulin (LAI) or non-insulin therapy using continuous glucose monitors is limited. This study evaluates change in HbA1c from baseline to 6mo and baseline to 12mo after starting a FreeStyle L
Publikováno v:
Diabetes. 69
Continuous glucose monitoring (CGM) in patients with diabetes using intensive insulin therapy has been well established, but there are limited data for CGM in other diabetes populations. We assessed HbA1c changes following a FreeStyle Libre prescript